Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Clinical Genitourinary Cancer|June 1, 2017
Genomic Characterization of Renal Medullary Carcinoma and Treatment OutcomesMaria I Carlo, Joshua Chaim, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer RiskTari A King, Melissa Pilewskie, Shirin Muhsen, et al.
Annals of Surgical Oncology|August 27, 2013
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapyLynn T Dengel, Kimberly J Van Zee, Tari A King, et al.
NPJ Breast Cancer|April 20, 2022
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastasesDavid B Page, Kathryn Beal, Stefanie N Linch, et al.
Clinical Breast Cancer|December 15, 2010
Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancerPamela Drullinsky, Steven M Sugarman, Monica N Fornier, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
BJS Open|January 18, 2022
Comparing outcomes of robotic versus open mesorectal excision for rectal cancerRosa M Jimenez-Rodriguez, Jessica Flynn, Sujata Patil, et al.
Oncoimmunology|November 25, 2020
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancerRosa M Jimenez-Rodriguez, Sujata Patil, Ajaratu Keshinro, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2021
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid featuresChristopher J Schwartz, Edi Brogi, Antonio Marra, et al.
Journal for Immunotherapy of Cancer|June 24, 2020
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapyYasser Ged, Joshua L Chaim, Renzo G DiNatale, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Clinical Genitourinary Cancer|June 1, 2017
Genomic Characterization of Renal Medullary Carcinoma and Treatment OutcomesMaria I Carlo, Joshua Chaim, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer RiskTari A King, Melissa Pilewskie, Shirin Muhsen, et al.
Annals of Surgical Oncology|August 27, 2013
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapyLynn T Dengel, Kimberly J Van Zee, Tari A King, et al.
NPJ Breast Cancer|April 20, 2022
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastasesDavid B Page, Kathryn Beal, Stefanie N Linch, et al.
Clinical Breast Cancer|December 15, 2010
Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancerPamela Drullinsky, Steven M Sugarman, Monica N Fornier, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
BJS Open|January 18, 2022
Comparing outcomes of robotic versus open mesorectal excision for rectal cancerRosa M Jimenez-Rodriguez, Jessica Flynn, Sujata Patil, et al.
Oncoimmunology|November 25, 2020
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancerRosa M Jimenez-Rodriguez, Sujata Patil, Ajaratu Keshinro, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2021
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid featuresChristopher J Schwartz, Edi Brogi, Antonio Marra, et al.
Journal for Immunotherapy of Cancer|June 24, 2020
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapyYasser Ged, Joshua L Chaim, Renzo G DiNatale, et al.
Pageof 23